MOD3 Pharma

MOD3 Pharma works with pharmaceutical partners to improve the solubility of hard-to-dose therapeutics.  The company’s core Peptelligence drug delivery technology allows for oral delivery of peptides and BCS class II, III, and IV small molecules. With MOD3 Pharma, SWK has the opportunity to become more operationally oriented, actively building a wholly-owned portfolio of milestones and royalties throughout-licensing activities.

 

SWK's valuation and use of MOD3 Pharma